Concepedia

Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial

Paul Cremer, Antonio Abbate, Kristin Hudock, Carla McWilliams, J.P. Mehta, Steven Y. Chang, Calvin C. Sheng, Benjamín Van Tassell, Aldo Bonaventura, Alessandra Vecchié,

The Lancet Rheumatology · 2021 · 68 citations · 19 references

DOIFull text

Open access

References

19

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang, Yeming Wang, Xingwang Li et al. · The Lancet · 2020 · 51.3K citations · Full text

, , +8

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou, Ting Yu, Ronghui Du et al. · The Lancet · 2020 · 28.8K citations · Full text

, , +11

Dexamethasone in Hospitalized Patients with Covid-19

New England Journal of Medicine · 2020 · 9.9K citations · Full text

Dexamethasone in Hospitalized Patients with Covid-19.

DiRROS repository (University of Maribor) · 2020 · 8K citations · Full text

Remdesivir for the Treatment of Covid-19 — Final Report

John H. Beigel, Kay M Tomashek, Lori E. Dodd et al. · New England Journal of Medicine · 2020 · 7.6K citations · Full text